State Street Corp Ocugen, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, State Street Corp holds 5,866,108 shares of OCGN stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,866,108
Previous 15,824,517
62.93%
Holding current value
$4.22 Million
Previous $15.7 Million
70.05%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OCGN
# of Institutions
126Shares Held
68.1MCall Options Held
634KPut Options Held
291K-
Black Rock Inc. New York, NY17.9MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$4.74 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.77 Million0.1% of portfolio
-
Northern Trust Corp Chicago, IL2.41MShares$1.73 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $156M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...